Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;15(1):21073.
doi: 10.1038/s41598-025-07411-w.

Predictive value of AMH in late reproductive age: a retrospective cohort study

Nejc Kozar  1   2 , Vida Gavrić Lovrec  3   4 , Borut Kovačič  3 , Milan Reljič  3   4
Affiliations

Predictive value of AMH in late reproductive age: a retrospective cohort study

Nejc Kozar et al. Sci Rep. .

Abstract

This study evaluates the predictive value of Anti-Müllerian Hormone (AMH) levels on outcomes in medically assisted reproduction (MAR), with a focus on women of late reproductive age. AMH, produced by granulosa cells in ovarian follicles, serves as an important indicator of ovarian reserve. A retrospective cohort analysis was conducted, encompassing 4891 MAR cycles, to assess the age-specific predictive value of AMH for clinical pregnancy. The results indicate that AMH is significantly correlated with clinical pregnancy outcomes (p < 0.01) and demonstrates potential predictive value in women over 35 years of age, with its predictive capacity increasing notably with age (AUC = 0.62-0.69). However, in younger women, the correlation between AMH levels and MAR outcomes is weaker (AUC = 0.48-0.53). These findings highlight the importance of integrating AMH measurements with age when assessing fertility potential and tailoring MAR treatments, particularly for women approaching the end of their reproductive lifespan.

Keywords: AMH; Clinical pregnancy; IVF; Late reproductive age; MAR.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethics approval: Use of the database was approved by the Medical Ethics Committee of UKC Maribor under approval number UKC-MB-KME-48/24.

Figures

Fig. 1
Fig. 1
No. of collected oocytes stratified by age.
Fig. 2
Fig. 2
Relationship between AMH concentrations and age.
Fig. 3
Fig. 3
Significance of correlation between clinical pregnancy and AMH levels, stratified by age.
Fig. 4
Fig. 4
ROC comparison.
See this image and copyright information in PMC

References

    1. Clemente, N. D., Racine, C., Pierre, A. & Taieb, J. Anti-Müllerian hormone in female reproduction. Endocr. Rev.11(42), 753–782. 10.1210/endrev/bnab012 (2021). - DOI - PubMed
    1. Nilsson, E., Rogers, N. & Skinner, M. K. Actions of anti-Müllerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction8(134), 209–221. 10.1530/REP-07-0119 (2007). - DOI - PMC - PubMed
    1. Bedenk, J., Vrtačnik-Bokal, E., & Virant-Klun, I. The Role of Anti-Müllerian Hormone (AMH) in Ovarian Disease and Infertility. (Springer). - PMC - PubMed
    1. Penzias, A. et al. Testing and interpreting measures of ovarian reserve: A committee opinion. Fertil. Steril.12(114), 1151–1157. 10.1016/j.fertnstert.2020.09.134 (2020). - DOI - PubMed
    1. Tal, R. et al. AMH highly correlates with cumulative live birth rate in women with diminished ovarian reserve independent of age. J. Clin. Endocrinol. Metab.8(106), 2754–2766. 10.1210/clinem/dgab168 (2021). - DOI - PubMed

LinkOut - more resources